Theranostics 2012; 2(3):313-317. doi:10.7150/thno.4007
Clinical Indications of 11C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse
1. Nuclear Medicine Department, San Raffaele Scientific Institute, Milan, Italy; Institute for Bioimaging and Molecular Physiology, National Research Council (IBFM-CNR), Milan, Italy;
2. Nuclear Medicine Unit, Azienda Ospedaliero-Universitaria di Bologna Policlinico S.Orsola-Malpighi, University of Bologna, Italy.
Picchio M, Castellucci P. Clinical Indications of 11C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse. Theranostics 2012; 2(3):313-317. doi:10.7150/thno.4007. Available from https://www.thno.org/v02p0313.htm
Several studies investigated the potential role of imaging modalities in prostate cancer patients in case of biochemical recurrence. However, the role of molecular imaging has not been well established yet. Considering the results of the literature and of our own experience, we tried to summarize the potential applications of 11C-choline PET/CT in prostate cancer patients in case of biochemical relapse for the detection of lymph node and distant recurrence.
Keywords: prostate cancer, choline PET/CT, restaging.